Eight months after Evusheld was authorized against Covid, only a tiny fraction of immunocompromised patients are taking it.
Crucial Drug to Protect Most Vulnerable Goes Vastly Underused
Comment
Show comments
Hide Comments
Eight months after Evusheld was authorized against Covid, only a tiny fraction of immunocompromised patients are taking it.
